Undervalued Large-Cap Growth Stocks on NAS July 2025

July 17, 2025

Growth Stocks

A company is considered a growth stock when it has grown its revenue significantly in the latest quarterly report.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Large-Cap

Large-Cap stocks have a market capitalization of $10 billion or more.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Growth Stocks

Stocks in this category are held primarily for capital appreciation and while they present upside opportunity, they also present downside risk.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
SRPT Sarepta Therapeutics 37.60 76.50 103.46 5730379 3661 0.00 0.0
ACHC Acadia Healthcare Co 22.61 44.00 94.60 2381117 2081 0.00 11.1
HTZ Hertz Global Holdings 6.55 11.91 81.90 11734970 2011 0.00 0.0
KC Kingsoft Cloud Holdings 11.17 19.32 72.95 1986471 2776 0.00 0.0
CZR Caesars Entertainment 26.88 44.00 63.71 4663008 5699 0.00 0.0
SNDK SanDisk 37.69 60.64 60.89 2367139 5465 0.00 0.0
BMRN Biomarin Pharmaceutical 58.07 92.00 58.43 2180190 11409 0.00 21.5
SATS EchoStar 17.73 28.00 57.97 3481984 5078 0.00 0.0
PENN PENN Entertainment 14.82 22.00 48.45 3492521 2475 0.00 0.0
IBRX ImmunityBio 2.64 3.90 47.76 10937387 2252 0.00 0.0
All data provided as at market close May 29, 2025.

Company Details

Sarepta Therapeutics

SRPT:NAS

Close Price

37.60

Our Valuation

76.50

% Difference

103.46

Market Cap ($M)

3661

P/E Ratio

0.0

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates.

Access the stockcalc valuation


Acadia Healthcare Co

ACHC:NAS

Close Price

22.61

Our Valuation

44.00

% Difference

94.60

Market Cap ($M)

2081

P/E Ratio

11.1

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Access the stockcalc valuation


Hertz Global Holdings

HTZ:NAS

Close Price

6.55

Our Valuation

11.91

% Difference

81.90

Market Cap ($M)

2011

P/E Ratio

0.0

Hertz Global Holdings Inc is engaged principally in the business of renting vehicles through Hertz, Dollar and Thrifty brands. The Company has identified two reportable segments: Americas RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in the U.S., Canada, Latin America and the Caribbean; International RAC: Rental of vehicles, as well as sales of vehicles and value-added services, in locations other than the U.S., Canada, Latin America and the Caribbean.

Access the stockcalc valuation


Kingsoft Cloud Holdings

KC:NAS

Close Price

11.17

Our Valuation

19.32

% Difference

72.95

Market Cap ($M)

2776

P/E Ratio

0.0

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Caesars Entertainment

CZR:NAS

Close Price

26.88

Our Valuation

44.00

% Difference

63.71

Market Cap ($M)

5699

P/E Ratio

0.0

Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024.

Access the stockcalc valuation


SanDisk

SNDK:NAS

Close Price

37.69

Our Valuation

60.64

% Difference

60.89

Market Cap ($M)

5465

P/E Ratio

0.0

SanDisk Corp designs, develops and manufactures data storage solutions using flash memory, proprietary controller and firmware technologies.

Access the stockcalc valuation


Biomarin Pharmaceutical

BMRN:NAS

Close Price

58.07

Our Valuation

92.00

% Difference

58.43

Market Cap ($M)

11409

P/E Ratio

21.5

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis.

Access the stockcalc valuation


EchoStar

SATS:NAS

Close Price

17.73

Our Valuation

28.00

% Difference

57.97

Market Cap ($M)

5078

P/E Ratio

0.0

Satellite television provides the bulk of EchoStar's revenue. The firm serves about 6 million US satellite customers, about 10% of the traditional television market. It launched an internet-based television offering under the Sling brand in 2015 and serves about 2 million customers on this platform. The firm's focus is now on the wireless market. EchoStar has amassed an extensive portfolio of spectrum licenses and is building a nationwide wireless network.

Access the stockcalc valuation


PENN Entertainment

PENN:NAS

Close Price

14.82

Our Valuation

22.00

% Difference

48.45

Market Cap ($M)

2475

P/E Ratio

0.0

Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets.

Access the stockcalc valuation


ImmunityBio

IBRX:NAS

Close Price

2.64

Our Valuation

3.90

% Difference

47.76

Market Cap ($M)

2252

P/E Ratio

0.0

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Sarepta Therapeutics and Acadia Healthcare are the most undervalued Large-Cap growth stocks on the NAS. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-large-cap-growth-stocks-nas-july-2025
Sarepta Therapeutics $SRPT and Acadia Healthcare $ACHC are the most undervalued Large-Cap growth stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-growth-stocks-nas-july-2025
Sarepta Therapeutics and Acadia Healthcare are the most undervalued Large-Cap growth stocks on the NAS. See the full list of undervalued growth stocks here: https://www.stockcalc.com/Blog/undervalued-large-cap-growth-stocks-nas-july-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.